Pulmonary toxicity in paediatric patients with relapsed or refractory Hodgkin lymphoma receiving brentuximab vedotin-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pulmonary toxicity in paediatric patients with relapsed or refractory Hodgkin lymphoma receiving brentuximab vedotin

Published:2018-09-10 Issue:2 Volume:183 Page:251-256
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Faulk Kelly E.¹,Sopfe Jenna M.¹^ORCID,Campbell Kristen²,Liptzin Deborah R.³,Liu Arthur K.¹,Franklin Anna R. K.¹,Cost Carrye R.¹

Affiliation:

1. Center for Cancer and Blood Disorders; Department of Paediatrics; University of Colorado School of Medicine; Aurora CO USA

2. Department of Paediatrics; University of Colorado School of Medicine; Aurora CO USA

3. Paediatric Respiratory Center; Department of Paediatrics; University of Colorado School of Medicine; Aurora CO USA

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.15586/fullpdf

Reference19 articles.

1. Brentuximab vedotin activity in diffuse large B-cell lymphoma with CD30 undetectable by visual assessment of conventional immunohistochemistry;Bartlett;Leukaemia & Lymphoma,2017

2. Clinical features and correlates of gemcitabine-associated lung injury: findings from the RADAR project;Belknap;Cancer,2006

3. Serious pulmonary toxicity in patients with Hodgkin's lymphoma with SGN-30, gemcitabine, vinorelbine, and liposomal doxorubicin is associated with an FcgammaRIIIa-158 V/F polymorphism;Blum;Annals of Oncology,2010

4. Severe pulmonary toxicity in patients with advanced-stage Hodgkin's disease treated with a modified bleomycin, doxorubicin, cyclophosphamide, vincristine, procarbazine, prednisone, and gemcitabine (BEACOPP) regimen is probably related to the combination of gemcitabine and bleomycin: a report of the German Hodgkin's Lymphoma Study Group;Bredenfeld;Journal of Clinical Oncology,2004

5. Morbidity and mortality in long-term survivors of Hodgkin lymphoma: a report from the Childhood Cancer Survivor Study;Castellino;Blood,2011

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neurocognitive impairment associated with chronic morbidity in long-term survivors of Hodgkin Lymphoma;Blood Advances;2023-11-30

2. Infectious Complications of Targeted Therapies in Children with Leukemias and Lymphomas;Cancers;2022-10-14

3. Evaluation of pulmonary toxicities in lymphoma patients receiving brentuximab vedotin;Leukemia & Lymphoma;2022-07-25

4. Brentuximab vedotin in the treatment of paediatric patients with relapsed or refractory Hodgkin's lymphoma: Results of a real‐life study;Pediatric Blood & Cancer;2022-06-02

5. Vital organ sparing with proton therapy for pediatric Hodgkin lymphoma: Toxicity and outcomes in 50 patients;Radiotherapy and Oncology;2022-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3